Sharon Bio-Medicine informs about financial results

23 Feb 2018 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sharon Bio-Medicine has informed that the resolution professional on 22 February 2018 has approved and considered the standalone unaudited Financial results of the company with the Limited review report for the quarter and nine months ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×